NASH Observatory

⏿ The PanNASH Initiative is an interactive web-based platform presenting global NASH statistics to inform NASH control and research.

NASH Treatment: Review of Current and Future Therapies for Non-Alcoholic Steatohepatitis

NASH Treatment
Prof. Stephen Harrison (USA) reviews current and future therapies for Non-Alcoholic Steatohepatitis (NASH). After a focus on the pathogenesis of NASH and the different pathways on how underlying steatohepatitis is developed, he presents his expert perspective on how patient outcomes can be improved.
Read MoreNASH Treatment: Review of Current and Future Therapies for Non-Alcoholic Steatohepatitis

NAFLD and structural heart, systolic and diastolic dysfunction: a meta-analysis

Authors: Yong JN, Ng CH, Lee CW, et al.
Published in Hepatol Int 2022
Several studies have documented a relationship between non-alcoholic fatty liver disease (NAFLD) and structural heart disease, particularly diastolic function. This meta-analysis by J. N. Yong et al. (Yong Loo.....
Read MoreNAFLD and structural heart, systolic and diastolic dysfunction: a meta-analysis

Role of age, gender and ethnicity in the association between visceral adiposity index and non-alcoholic fatty liver disease among US adults (NHANES 2003-2018): cross-sectional study

Authors: Li Q, Wang L, Wu J, et al.
Published in BMJ Open 2022
In this cross-sectional population-based study, the authors aimed to explore the association between visceral adiposity index and NAFLD in the general US.....
Read MoreRole of age, gender and ethnicity in the association between visceral adiposity index and non-alcoholic fatty liver disease among US adults (NHANES 2003-2018): cross-sectional study

Advanced liver fibrosis in NAFLD and antiplatelet therapy: a meta-analysis

Authors: Thongtan T, Deb A, Vutthikraivit W, et al.
Published in Indian J Gastroenterol 2022
Recent studies have found the new use of antiplatelet agents for antifibrotic benefits in NAFLD, but human studies are still limited. The authors of this meta-analysis aimed to combine the findings.....
Read MoreAdvanced liver fibrosis in NAFLD and antiplatelet therapy: a meta-analysis

SUBSCRIBE & FOLLOW US

SUBSCRIBE TO OUR MONTHLY NEWSLETTER TO GET THE LATEST UPDATES